-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RQ9UKJmGCp0iILSLQsSz1LogzP+dOj906B9R7V/7O4Za+hvgybgtF5sZ/mt6trhG Lrtr3kI7mW/FeyUYAfBBfQ== 0001144204-06-005306.txt : 20060213 0001144204-06-005306.hdr.sgml : 20060213 20060213112311 ACCESSION NUMBER: 0001144204-06-005306 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060213 DATE AS OF CHANGE: 20060213 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ZHANG XUMU CENTRAL INDEX KEY: 0001248896 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: 276 CAMEBOT LANE CITY: STATE COLLEGE STATE: PA ZIP: 16803 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VioQuest Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000745788 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 581486040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60301 FILM NUMBER: 06601464 BUSINESS ADDRESS: STREET 1: 7 DEER PARK DRIVE, SUITE E STREET 2: PRINCETON CORPORATE PLAZA CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 BUSINESS PHONE: 732-274-0399 MAIL ADDRESS: STREET 1: 7 DEER PARK DRIVE, SUITE E STREET 2: PRINCETON CORPORATE PLAZA CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 FORMER COMPANY: FORMER CONFORMED NAME: VioQuest Pharmaceuticals DATE OF NAME CHANGE: 20041117 FORMER COMPANY: FORMER CONFORMED NAME: CHIRAL QUEST INC DATE OF NAME CHANGE: 20030305 FORMER COMPANY: FORMER CONFORMED NAME: SURG II INC DATE OF NAME CHANGE: 20020605 SC 13G/A 1 v035374_sc13ga.txt SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(b) (Amendment No.1)(1) VioQuest Pharmacueticals, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.001 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 927625 10 3 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2005 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |_| Rule 13d-(c) |X| Rule 13d-1(d) - ---------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 927625 10 3 13G Page 2 of 5 Pages - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Xumu Zhang, Ph.D. - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION USA - -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES BENEFICIALLY 2,943,288 OWNED BY ------------------------------------------------------------ EACH 6. SHARED VOTING POWER REPORTING PERSON 0 WITH ------------------------------------------------------------ 7. SOLE DISPOSITIVE POWER 2,943,288 ------------------------------------------------------------ 8. SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,943,288 - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.3% - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- CUSIP No. 927625 10 3 13G Page 3 of 5 Pages - -------------------------------------------------------------------------------- Item 1(a). Name of Issuer: VioQuest Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- Item 1(b). Address of Issuer's Principal Executive Offices: 7 Deer Park Drive, Suite E, Monmouth Junction, NJ 08852 - -------------------------------------------------------------------------------- Item 2(a). Name of Person Filing: Xumu Zhang, Ph.D. - -------------------------------------------------------------------------------- Item 2(b). Address of Principal Business Office, or if None, Residence: 7 Deer Park Drive, Suite E, Monmouth Junction, NJ 08852 - -------------------------------------------------------------------------------- Item 2(c). Citizenship: USA - -------------------------------------------------------------------------------- Item 2(d). Title of Class of Securities: Common Stock, $.001 par value - -------------------------------------------------------------------------------- Item 2(e). CUSIP Number: 927625 10 3 - -------------------------------------------------------------------------------- Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a)|_| Broker or dealer registered under Section 15 of the Exchange Act. (b)|_| Bank as defined in Section 3(a)(6) of the Exchange Act. (c)|_| Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d)|_| Investment company registered under Section 8 of the Investment Company Act. (e)|_| An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f)|_| An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g)|_| A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h)|_| A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i)|_| A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j)|_| Group, in accordance with Rule 13d-1(b)(1)(ii)(J). - -------------------------------------------------------------------------------- CUSIP No. 927625 10 3 13G Page 4 of 5 Pages - -------------------------------------------------------------------------------- Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 2,943,288 (includes 325,026 shares issuable upon exercise of an option which is currently vested) -------------------------------------------------------------------------- (b) Percent of class: 6.3% -------------------------------------------------------------------------- (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 2,943,288 -------------------------------------------------------------------- (ii) Shared power to vote or to direct the vote: 0 -------------------------------------------------------------------- (iii) Sole power to dispose or to direct the disposition of: 2,943,288 -------------------------------------------------------------------- (iv) Shared power to dispose or to direct the disposition of: 0 - -------------------------------------------------------------------------------- Item 5. Ownership of Five Percent or Less of a Class. N/A - -------------------------------------------------------------------------------- Item 6. Ownership of More Than Five Percent on Behalf of Another Person. N/A - -------------------------------------------------------------------------------- Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. N/A - -------------------------------------------------------------------------------- Item 8. Identification and Classification of Members of the Group. N/A - -------------------------------------------------------------------------------- Item 9. Notice of Dissolution of Group. N/A - -------------------------------------------------------------------------------- Item 10. Certifications. (a) Not applicable (b) Not applicable - -------------------------------------------------------------------------------- CUSIP No. 927625 10 3 13G Page 5 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 11, 2006 /s/ Xumu Zhang ------------------------------- Xumu Zhang -----END PRIVACY-ENHANCED MESSAGE-----